BÜHLMANN fCAL® turbo is for Research Use Only in the US. Not to be used in diagnostic procedures.
Health Canada License: 96808
Unilabs Portugal, a private European lab chain, made a comprehensive evaluation of different Calprotectin assays on the market and found many discrepancies with assays from other suppliers. Finally, they chose the BÜHLMANN fCAL® turbo simply because it is faster, easier and reliable with a simple non-demanding workflow. Watch the interview with Dr. Carlos Torres. Find a short version and the full interview below.
Interview with Dr. João Pedro Ramos, Torres Grupo Unilabs Portugal
Dr. João Pedro Ramos, MD Clinical Pathologist – Medical Laboratory Director, Unilabs Portugal
The Unilabs Group is currently the largest lab in Portugal. And we just grew by acquisition to almost 8,000 patients a day. That means we are currently the largest Portuguese laboratory and one of the largest laboratories in Europe. We cover all areas of clinical analysis from haematology to transfusion medicine, all immunoassays, genetics, pathological anatomy, and molecular biology.
Dr. João Pedro Ramos, several months ago you decided to implement the BÜHLMANN fCAL® turbo on your Advia Chemistry system. Can you tell me why?
What advantages do you see in the routine use BÜHLMANN fCAL® turbo?
Can you tell me about your experience implementing the BÜHLMANN fCAL® turbo assay on your Advia clinical chemistry analyzer?
During the evaluation of the BÜHLMANN fCAL® turbo technology, did you also consider and evaluate other methods?
Which extraction method do you use? What is your impression of the technique?
*This interview has been edited for clarity and brevity.
Laboratorio Germano de Sousa, a large privately hold clinical laboratory in Portugal with over 1.2 Mio patient samples per year runs the BÜHLMANN fCAL®turbo on an Advia 2400 chemistry analyzer. The analyzer is attached to total laboratory automation (TLA) solution from Siemens/Inpeco. Find a short version and the full interview below.